Each day about 1800 children worldwide become infected with HIV (human immunodeficiency virus), the majority of them newborns. Most newborns and children with HIV became infected through pregnancy, the birth process, or breast milk from HIV-infected mothers (mother-to-child transmission). Although there is no cure for HIV or AIDS (acquired immunodeficiency syndrome), treatment is available to prolong life and to prevent transmission of the virus from a mother to her baby. The July 19, 2006, issue of JAMA includes an article about how treatment of HIV in children in the United States has led to a decline in HIV-associated infections.
Grahic Jump Location
Take measures to protect yourself from contracting HIV. HIV is spread through unprotected sex with an infected partner, through infected blood, and through contaminated needles.
Maintain good health during pregnancy. Avoid tobacco, alcohol and illicit drugs, and risky sexual behaviors while pregnant. Get proper nutrition and seek regular prenatal care.
Get tested for HIV, especially since many people infected with HIV have no symptoms. It is recommended that all pregnant women be tested for HIV. Your doctor can counsel you about HIV testing. Many sites offer anonymous testing.
There are several precautions a pregnant woman infected with HIV can take to prevent the spread of HIV to her baby, reducing the risk to a low level. Treatment of HIV infection with antiretroviral drugs (medications that help fight HIV) during pregnancy and labor can help lower the risk of transmission. Preventive treatment for the newborn can also help reduce the risk of transmitting the virus. Taking HIV medications properly is necessary to prevent the virus from becoming resistant (more difficult to treat). Some antiretroviral drugs are not recommended for use during pregnancy. Discuss the proper treatment regimen and monitoring with your doctor.
Having a cesarean section birth may reduce the chance of transmitting the virus in some women. There are risks associated with cesarean section. Discuss with your doctor whether a scheduled cesarean section or vaginal delivery would be best for you.
In the United States, women infected with HIV should use formula and should not breastfeed in order to prevent transmission of the virus to the baby through breast milk.
Babies are tested for HIV differently than adults. Discuss how best to test for HIV in babies with your doctor.
It is recommended that babies born to HIV-infected mothers receive an antiretroviral drug such as zidovudine after birth. They should also receive medication to prevent HIV-associated infections. Discuss the recommended drugs and follow-up with your doctor.
US Department of Health and Human Serviceshttp://www.aidsinfo.nih.gov
National Institute of Allergy and Infectious Diseaseshttp://www.niaid.nih.gov
Centers for Disease Control and Preventionhttp://www.cdc.gov/hiv/
World Health Organizationhttp://www.who.int/hiv/en
Joint United Nations Programme on HIV/AIDShttp://www.unaids.org
To find this and previous JAMA Patient Pages, go to the Patient Page link on JAMA's Web site at http://www.jama.com. A Patient Page on HIV was published in the July 14, 2004, issue.
Sources: US Department of Health and Human Services, National Institutes of Health, Centers for Disease Control and Prevention, World Health Organization, Joint United Nations Programme on HIV/AIDS
The JAMA Patient Page is a public service of JAMA. The information and recommendations appearing on this page are appropriate in most instances, but they are not a substitute for medical diagnosis. For specific information concerning your personal medical condition, JAMA suggests that you consult your physician. This page may be photocopied noncommercially by physicians and other health care professionals to share with patients. To purchase bulk reprints, call 203/259-8724.
TOPIC: HIV/AIDS
Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature
Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal
Instructions
Comments are moderated and will appear on the site at the discretion of the Journal of American Medical Association editors. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest* Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Customize your page view by dragging & repositioning the boxes below.
Users' Guides to the Medical Literature For example, a trial of intravenous immunoglobulin in advanced human immunodeficiency infection...
The Rational Clinical Examination Evidence Summary and Review 3
All results at JAMAevidence.com >
and access these and other features:
Register Now
Enter your username and email address. We'll send you a reminder to the email address on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.